AP
ABMD

AtonRa Partners’s Abiomed Inc ABMD Stock Holding History

AtonRa Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,803
Closed -$1.18M – 116
2022
Q3 		$1.18M Sell
4,803
-963
-17% -$260K 1.16% 27
2022
Q2 		$1.43M Sell
5,766
-2,779
-33% -$750K 1.31% 16
2022
Q1 		$2.83M Sell
8,545
-3,165
-27% -$974K 1.54% 14
2021
Q4 		$4.21M Buy
11,710
+185
+2% +$62.5K 1.46% 17
2021
Q3 		$3.75M Buy
11,525
+1,306
+13% +$442K 1.25% 26
2021
Q2 		$3.19M Sell
10,219
-340
-3% -$104K 1.17% 30
2021
Q1 		$3.37M Sell
10,559
-2,656
-20% -$850K 1.5% 12
2020
Q4 		$4.28M Buy
+13,215
New +$3.66M 2.1% 5

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AtonRa Partners's ABMD Position: Q4 2022 in Review

AtonRa Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,803 shares — an estimated $1.18M sold.

AtonRa Partners first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $4.28M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • AtonRa Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • AtonRa Partners sold 4,803 Abiomed Inc shares in Q4 2022, an estimated $1.18M.
  • AtonRa Partners first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • AtonRa Partners's Abiomed Inc position peaked at $4.28M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on AtonRa Partners's 13F filing for Q4 2022, filed 2 Feb 2023.